These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 2969747)

  • 21. Nafarelin in the treatment of pelvic pain caused by endometriosis.
    Shaw RW
    Am J Obstet Gynecol; 1990 Feb; 162(2):574-6. PubMed ID: 2137972
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and safety of nafarelin in the treatment of endometriosis.
    Henzl MR; Kwei L
    Am J Obstet Gynecol; 1990 Feb; 162(2):570-4. PubMed ID: 2137971
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nafarelin in the management of endometriosis: quality of life assessment.
    Burry KA
    Am J Obstet Gynecol; 1992 Feb; 166(2):735-9. PubMed ID: 1531576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone analogs in the treatment of endometriomas.
    Schenken RS
    Am J Obstet Gynecol; 1990 Feb; 162(2):579-81. PubMed ID: 2137974
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nafarelin for endometriosis: a large-scale, danazol-controlled trial of efficacy and safety, with 1-year follow-up. The Nafarelin European Endometriosis Trial Group (NEET).
    Fertil Steril; 1992 Mar; 57(3):514-22. PubMed ID: 1531464
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [2nd International Symposium on GnRH-Analogues in Cancer and Human Reproduction. Nafarelin, a new versatile GnRH agonist analogue. Geneva, 9 November 1990].
    Gynakologe; 1991 Feb; (1 Suppl):1-4. PubMed ID: 1674490
    [No Abstract]   [Full Text] [Related]  

  • 27. New therapy for endometriosis.
    Barbieri RL
    N Engl J Med; 1988 Feb; 318(8):512-4. PubMed ID: 2963214
    [No Abstract]   [Full Text] [Related]  

  • 28. Gonadotropin-releasing hormone analogs: update on new findings.
    Henzl MR
    Am J Obstet Gynecol; 1992 Feb; 166(2):757-61. PubMed ID: 1531579
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rationale in use of LHRH analogues in endometriosis.
    Shaw RW
    Horm Res; 1989; 32 Suppl 1():110-4. PubMed ID: 2533143
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial.
    Henzl MR; Corson SL; Moghissi K; Buttram VC; Berqvist C; Jacobson J
    N Engl J Med; 1988 Feb; 318(8):485-9. PubMed ID: 2963213
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Recent data on endometriosis].
    de Noblens C
    Rev Fr Gynecol Obstet; 1991 Dec; 86(12):747-50. PubMed ID: 1837937
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
    Moncayo R; Wilken J; Wilde N; Kann D; Leidenberger F
    Obstet Gynecol; 1991 Jan; 77(1):169-70. PubMed ID: 1824574
    [No Abstract]   [Full Text] [Related]  

  • 33. Possible short-term memory loss associated with nafarelin acetate.
    Kortepeter C; Macmillan M; Ferrell R
    Ann Pharmacother; 1992 Feb; 26(2):169-71. PubMed ID: 1532517
    [TBL] [Abstract][Full Text] [Related]  

  • 34. More on "misuse of statistics".
    Adamson GD
    Fertil Steril; 1990 Oct; 54(4):743-4. PubMed ID: 2145186
    [No Abstract]   [Full Text] [Related]  

  • 35. Antiendometrial antibodies in endometriosis measured by an enzyme-linked immunosorbent assay before and after treatment with danazol and nafarelin.
    Kennedy SH; Starkey PM; Sargent IL; Hicks BR; Barlow DH
    Obstet Gynecol; 1990 Jun; 75(6):914-8. PubMed ID: 2140439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. On the origin and significance of serum CA-125 concentrations in 97 patients with endometriosis before, during, and after buserelin acetate, nafarelin, or danazol.
    Franssen AM; van der Heijden PF; Thomas CM; Doesburg WH; Willemsen WN; Rolland R
    Fertil Steril; 1992 May; 57(5):974-9. PubMed ID: 1533376
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is it possible to prevent bone loss in young women treated with luteinizing hormone-releasing hormone agonists?
    Riis BJ; Christiansen C; Johansen JS; Jacobson J
    J Clin Endocrinol Metab; 1990 Apr; 70(4):920-4. PubMed ID: 2138631
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An overview of treatments for endometriosis.
    Brown J; Farquhar C
    JAMA; 2015 Jan; 313(3):296-7. PubMed ID: 25603001
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined treatment of endometriosis. GnRH agonists and laparoscopic surgery.
    Hemmings R
    J Reprod Med; 1998 Mar; 43(3 Suppl):316-20. PubMed ID: 9564667
    [TBL] [Abstract][Full Text] [Related]  

  • 40. GnRH analogues in the treatment of endometriosis.
    Erickson LD; Ory SJ
    Obstet Gynecol Clin North Am; 1989 Mar; 16(1):123-45. PubMed ID: 2526312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.